HUTCHMED (China) Limited (HCM) Q2 2025 Earnings Call Transcript

2025-08-08 03:59:30 ET

HUTCHMED (China) Limited (HCM)

Q2 2025 Earnings Conference Call

August 07, 2025, 8:00 AM ET

Company Participants

Chig Fung Cheng - CFO & Executive Director

David Ng - Head of Investor Relations & Capital Strategies

George Yuan - Corporate Participant

Ming Shi - Executive VP, Head of R&D and Chief Medical Officer

Wei-Guo Su - CEO, Chief Scientific Officer & Executive Director

Conference Call Participants

Chen Chen - UBS Investment Bank, Research Division

Matthew Yan - Unidentified Company

Paul Choi - Goldman Sachs Group, Inc., Research Division

Presentation

David Ng

Hello, everyone. This is David Ng, Head of Investor Relations of HUTCHMED. Thank you for joining HUTCHMED 2025 Interim Result Presentation. Our result and presentation slides have already been posted on our homepage as well as on the Hong Kong Stock Exchange website.

Just a quick moment on the disclaimer. The performance and results of operation of HUTCHMED Group contained within this presentation are historical in nature, and past performance is no guarantee of future results, and actual results may vary materially from those set forth in the forward-looking statements....

Read the full article on Seeking Alpha

For further details see: